- Home
- IZM vs RVPH Comparison
IZM vs RVPH Comparison
Compare IZM & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- RVPH
- Stock Information
- Founded
- IZM 2011
- RVPH 2006
- Country
- IZM China
- RVPH United States
- Employees
- IZM N/A
- RVPH N/A
- Industry
- IZM Consumer Electronics/Video Chains
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- IZM Consumer Discretionary
- RVPH Health Care
- Exchange
- IZM Nasdaq
- RVPH Nasdaq
- Market Cap
- IZM 31.8M
- RVPH 32.8M
- IPO Year
- IZM 2023
- RVPH N/A
- Fundamental
- Price
- IZM $2.51
- RVPH $0.40
- Analyst Decision
- IZM
- RVPH Strong Buy
- Analyst Count
- IZM 0
- RVPH 5
- Target Price
- IZM N/A
- RVPH $9.00
- AVG Volume (30 Days)
- IZM 31.8K
- RVPH 3.8M
- Earning Date
- IZM 07-29-2025
- RVPH 08-13-2025
- Dividend Yield
- IZM N/A
- RVPH N/A
- EPS Growth
- IZM N/A
- RVPH N/A
- EPS
- IZM N/A
- RVPH N/A
- Revenue
- IZM $180,553,977.00
- RVPH N/A
- Revenue This Year
- IZM N/A
- RVPH N/A
- Revenue Next Year
- IZM N/A
- RVPH N/A
- P/E Ratio
- IZM N/A
- RVPH N/A
- Revenue Growth
- IZM N/A
- RVPH N/A
- 52 Week Low
- IZM $1.18
- RVPH $0.30
- 52 Week High
- IZM $3.19
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- IZM 50.31
- RVPH 36.63
- Support Level
- IZM $2.50
- RVPH $0.38
- Resistance Level
- IZM $2.65
- RVPH $0.45
- Average True Range (ATR)
- IZM 0.10
- RVPH 0.04
- MACD
- IZM -0.02
- RVPH 0.01
- Stochastic Oscillator
- IZM 32.35
- RVPH 58.54
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.